(Q33852953)

29 July 2017

1 reference

title

In vivo monitoring of drugs using radiotracer techniques (English)

1 reference

29 July 2017

Saleem A

1

1 reference

29 July 2017

Aboagye EO

series ordinal

2

1 reference

29 July 2017

Price PM

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

Advanced Drug Delivery Reviews

29 July 2017

1 reference

29 July 2017

41

1 reference

29 July 2017

21-39

1 reference

29 July 2017

1

1 reference

Population and Bayesian pharmacokinetics in oncology

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Asymmetric synthesis of a precursor for the automated radiosynthesis of S-(3'-t-butylamino-2'-hydroxypropoxy)-benzimidazol-2-[11C]one (S-[11C]CGP 12177) as a preferred radioligand for beta-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Breast cancer: PET imaging of estrogen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Spectral analysis of dynamic PET studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: a feasibility study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Fluorouracil: biochemistry and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Survival and response to chemotherapy for advanced colorectal adenocarcinoma: an Eastern Cooperative Oncology Group report

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Dosimetry and preliminary human studies of 18F-5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

An improved synthesis of 18F-5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Perfusion of colorectal liver metastases and uptake of fluorouracil assessed by H2(15)O and [18F]uracil positron emission tomography (PET)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Noninvasive determination of the arterial input function of an anticancer drug from dynamic PET scans using the population approach

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Human tumor fluorouracil trapping: clinical correlations of in vivo 19F nuclear magnetic resonance spectroscopy pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Association of intratumoral pharmacokinetics of fluorouracil with clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

The discovery and profile of fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Toxicological profile and safety evaluation of antifungal azole derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

The noninvasive assessment of myocardial viability

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Assessment of regional myocardial ischemia by positron-emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Local cerebral metabolic changes in acute ischemic strokes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Enzymology of cancer cells (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Enzymology of cancer cells (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

FDG-PET for predicting the prognosis of malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Changes of cerebral blood flow, and oxygen and glucose metabolism following radiochemotherapy of gliomas: a PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Effects of radiotherapy determined by 11C-methyl-L-methionine positron emission tomography in patients with primary cerebral malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Positron emission tomography with L-methyl-11C-methionine in the monitoring of therapy response in muscle-invasive transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Carbon-11-methionine and PET in evaluation of treatment response of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Metabolic changes of glioma following chemotherapy: an experimental study using four PET tracers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Imaging dopamine receptors in the human brain by positron tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

A Method for the In Vivo Investigation of the Serotonergic 5-HT2Receptors in the Human Cerebral Cortex Using Positron Emission Tomography and18F-Labeled Setoperone

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Visualization by positron emission tomography of the apparent regional heterogeneity of central type benzodiazepine receptors in the brain of living baboons.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

The synthesis of 7 alpha-methyl-substituted estrogens labeled with fluorine-18: potential breast tumor imaging agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Synthesis of [18F]fluoro-labeled progestins for PET

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Central D1- and D2-receptor occupancy during antipsychotic drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

The clinical relevance of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

P-glycoproteins: mediators of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Verapamil with mitoxantrone for advanced ovarian cancer: a negative phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Antibody-directed enzyme prodrug therapy (ADEPT) for treatment of major solid tumour disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Preliminary study of cardiac accumulation of F-18 fluorotamoxifen in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Pharmacokinetics of 11C-labelled BCNU and SarCNU in gliomas studied by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

The concentration of bleomycin labeled with Co-57 in primary and metastatic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

In vivo measurements of the fraction of dose of bleomycin labeled with cobalt 57 delivered to human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Coronary dilation with standard dose dipyridamole and dipyridamole combined with handgrip

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Comparative Effects of Enalapril and Verapamil on Myocardial Blood Flow in Systemic Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Dexamethasone treatment of brain tumor patients: effects on regional cerebral blood flow, blood volume, and oxygen utilization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Positron emission tomographic assessment of cerebral hemocirculation and glucose metabolism in malignant glioma following treatment with intracarotid recombinant human tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

Regional cerebral glucose transport in insulin-dependent diabetic patients studied using [11C]3-O-methyl-D-glucose and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900054-X

7 January 2021

10.1016/S0169-409X(99)00054-X

Identifiers

DOI

1 reference

29 July 2017

1 reference